Wednesday, July 8, 2026

pharma · Gout · Asthma

Sunshine Guojian Pharmaceutical

Sunshine Guojian Pharmaceutical is a pharma organization headquartered in FORT LAUDERDALE, FL, CN. Primary therapeutic focus areas include Gout, Asthma, Type 2 Diabetes, Dermatitis, Atopic, Chronic Hepatitis C. NovaPharm

FORT LAUDERDALE, FL, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
FORT LAUDERDALE, FL, CN
Programs
165
Drugs
80
Patents
121
Clinical program

Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg

Phase 3 · small molecule · Acute Gout

Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg for Acute Gout is a Phase 3 program (small_molecule) at Sunshine Guojian Pharmaceutical (Shanghai) Co., with 2 ClinicalTrials.gov record(s).

Internal code SSGJ-613-AG-III-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Phase
Phase 3
Modality
small_molecule
Indication
Acute Gout
Status
active
Trials
2